The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...

The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.

JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.

KSHB002, a 125 mg/mL pre-filled syringe injection ... “We are thrilled with the results of our Phase 1 study and are excited to move forward with our global Phase 3 efficacy and safety trial.

The biosimilar's safety and immunogenicity profiles were found to be comparable to those of the reference product in the ...

The syringe filling machine industry is experiencing significant growth due to the increasing demand for injectable medications, particularly with the rise of biologics, vaccines, and precision ...